This article was originally published by HCPLive. In patients with polymyalgia rheumatica who relapsed while tapering prednisone, those receiving sarilumab were significantly more likely to achieve ...

The increasing prevalence of polymyalgia rheumatica among the elderly population is boosting the adoption of polymyalgia rheumatica treatment to efficiently control painful myalgia. Furthermore, the ...

This page lists all known medications that could potentially lead to 'Polymyalgia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Background: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Diagnosing giant cell arteritis and polymyalgia rheumatica can “fascinate” and cause “trepidation” ...

Polymyalgia rheumatica (PMR) is an inflammatory disorder that causes severe muscle pain, muscle stiffness, muscle spasms and cramping on both sides of the body, particularly in the shoulders, neck, ...

Please provide your email address to receive an email when new articles are posted on . “Giant cell arteritis is a heterogeneous disorder with a variety of recognized clinical presentations,” Robert ...

March 12, 2012 — Diagnosis of polymyalgia rheumatica (PMR) has started to move from the realm of clinical intuition toward a more objective approach, after the release of provisional classification ...

One day, Mr. Black, a 60-year-old healthy man, suddenly experienced severe aching, stiffness and pain in his shoulders, arms, hips and legs. Within several weeks, he had gone from walking and ...

DEAR DR. GOTT: My doctor diagnosed me with polymyalgia. I have pain in the back of my head, shoulders and lower back that usually occurs at night and goes away when I get up in the morning. I’m 78 ...

Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating ...

Glucocorticoids are the mainstay of therapy for polymyalgia rheumatica (PMR). Although doses used for this disease are typically low (< 20 mg/day), therapy can often be used for several years.